ATE194911T1 - Anwendung von selegilin in tiermedizin - Google Patents

Anwendung von selegilin in tiermedizin

Info

Publication number
ATE194911T1
ATE194911T1 AT94400949T AT94400949T ATE194911T1 AT E194911 T1 ATE194911 T1 AT E194911T1 AT 94400949 T AT94400949 T AT 94400949T AT 94400949 T AT94400949 T AT 94400949T AT E194911 T1 ATE194911 T1 AT E194911T1
Authority
AT
Austria
Prior art keywords
selegiline
application
veterinary medicine
cats
dogs
Prior art date
Application number
AT94400949T
Other languages
English (en)
Inventor
Marie Sophie Filhol
Thierry Pobel
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26230300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE194911(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9305305A external-priority patent/FR2704756B1/fr
Priority claimed from FR9315495A external-priority patent/FR2713930B3/fr
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Application granted granted Critical
Publication of ATE194911T1 publication Critical patent/ATE194911T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
AT94400949T 1993-05-04 1994-05-02 Anwendung von selegilin in tiermedizin ATE194911T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9305305A FR2704756B1 (fr) 1993-05-04 1993-05-04 Utilisation de la sélégiline en médecine vétérinaire.
FR9315495A FR2713930B3 (fr) 1993-12-22 1993-12-22 Utilisation de la Sélégiline en médecine vétérinaire.

Publications (1)

Publication Number Publication Date
ATE194911T1 true ATE194911T1 (de) 2000-08-15

Family

ID=26230300

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94400949T ATE194911T1 (de) 1993-05-04 1994-05-02 Anwendung von selegilin in tiermedizin

Country Status (9)

Country Link
US (1) US5547995B1 (de)
EP (1) EP0623344B1 (de)
AT (1) ATE194911T1 (de)
CA (1) CA2122780C (de)
DE (1) DE69425345T2 (de)
DK (1) DK0623344T3 (de)
ES (1) ES2149850T3 (de)
GR (1) GR3034661T3 (de)
PT (1) PT623344E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983062A4 (de) 1997-05-21 2002-10-23 Sloan Kettering Inst Cancer Verfahren zur erhöhung der konzentration von ascobinsäure im hirngewebe von personen
US6262111B1 (en) * 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
HUP0401154A2 (hu) * 2001-07-20 2004-10-28 Pfizer Products Inc. NK-1 receptor antagonisták használata kutyák, macskák és lovak nemkívánatos viselkedésének módosítására
US20050079205A1 (en) * 2003-09-10 2005-04-14 Miller Cheryl C. Oleamide-containing composition for animal consumption
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
EP0578687A1 (de) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Verwendung von deprenyl zur unterhaltung,verhinderung von verlust oder zurückgewinnung von nervenzellefunktion

Also Published As

Publication number Publication date
GR3034661T3 (en) 2001-01-31
PT623344E (pt) 2000-12-29
EP0623344A1 (de) 1994-11-09
DK0623344T3 (da) 2000-12-18
DE69425345T2 (de) 2001-03-01
CA2122780C (fr) 2004-01-20
ES2149850T3 (es) 2000-11-16
EP0623344B1 (de) 2000-07-26
CA2122780A1 (fr) 1994-11-05
DE69425345D1 (de) 2000-08-31
US5547995B1 (en) 1998-01-27
US5547995A (en) 1996-08-20

Similar Documents

Publication Publication Date Title
DE69230046T2 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE69127175D1 (de) Antisens-Oligonukleotide zur Behandlung von Krebs
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69521994T2 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
ID26956A (id) Pencegahan raf kinase menggunakan simetris dan nonsimetris yang digantikan diphenil urea
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR1100384A (pt) Composto e formulação farmacêutica
ES2082834T3 (es) Composiciones con liberacion prolongada para tratar enfermedades periodontales.
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE194911T1 (de) Anwendung von selegilin in tiermedizin
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
DE69431199D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ES2096727T5 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
DE68909465D1 (de) Behandlung von pferdeviehbestand.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
MX9201825A (es) Composicion farmaceutica que contiene calcitonina.
DE69112718D1 (de) Verfahren und Zusammensetzung zur Behandlung von tierischen Exkrementen.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee